• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EASYTRAK 3 IS-1; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EASYTRAK 3 IS-1; IMPLANTABLE LEAD Back to Search Results
Model Number 4549
Medical Device Problem Codes Over-Sensing (1438); Pacing Problem (1439)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/09/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the cardiac resynchronization therapy defibrillator (crt-d) and this left ventricular (lv) lead exhibited oversensing of the atrial events in the lv channel.This caused a decrease in the lv pacing percentage and pacing inhibition.Technical services (ts) recommended turning lv sensing off and to bring in the patient to ensure lead measurements were in range.This lv lead remains in service.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that the cardiac resynchronization therapy defibrillator (crt-d) and this left ventricular (lv) lead exhibited oversensing of the atrial events in the lv channel.This caused a decrease in the lv pacing percentage and pacing inhibition.Technical services (ts) recommended turning lv sensing off and to bring in the patient to ensure lead measurements were in range.This lv lead remains in service.No adverse patient effects were reported.Additional information was received from the field.The oversensing was caused by the lead position.The patient was not pacer dependent.Lv sensing was turned off and it was confirmed lead measurements were normal.
 
Additional Manufacturer Narrative
Additional information added to b5.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 3 IS-1
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key23546604
Report Number2124215-2025-82717
Device Sequence Number9449076
Product Code LWP
UDI-Device Identifier00802526420399
UDI-Public(01)00802526420399(17)100912
Combination Product (Y/N)Y
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P010012
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2009
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date09/12/2010
Device Model Number4549
Device Catalogue Number4549
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/23/2025
Supplement Date Received by Manufacturer11/17/2025
Initial Report FDA Received Date11/13/2025
Supplement Report FDA Received Date11/24/2025
Date Device Manufactured09/12/2008
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age77 YR
Patient SexMale
-
-